PROLIXIN ENANTHATE Drug Patent Profile
✉ Email this page to a colleague
When do Prolixin Enanthate patents expire, and what generic alternatives are available?
Prolixin Enanthate is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in PROLIXIN ENANTHATE is fluphenazine enanthate. There are nineteen drug master file entries for this compound. Additional details are available on the fluphenazine enanthate profile page.
Summary for PROLIXIN ENANTHATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Patent Applications: | 899 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROLIXIN ENANTHATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PROLIXIN ENANTHATE
US Patents and Regulatory Information for PROLIXIN ENANTHATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | PROLIXIN ENANTHATE | fluphenazine enanthate | INJECTABLE;INJECTION | 016110-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |